110 related articles for article (PubMed ID: 6276105)
1. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience.
Livingston RB; McCracken JD; Trauth CJ; Chen T
Chest; 1982 Feb; 81(2):208-11. PubMed ID: 6276105
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
Xu K; Wang Y; Qi J; Zhao L; Wang P
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
[TBL] [Abstract][Full Text] [Related]
4. [Prognosis of small cell lung cancer with ipsilateral pleural effusion].
Oomori H; Matsui K; Nakagawa K; Masuda N; Itoh K; Kudoh S; Takifuji S; Kusunoki Y; Takada M; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1085-90. PubMed ID: 1324375
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
6. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.
Shepherd FA; Ginsberg RJ; Haddad R; Feld R; Sagman U; Evans WK; DeBoer G; Maki E
J Clin Oncol; 1993 Aug; 11(8):1592-7. PubMed ID: 8393098
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
8. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
9. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma.
Decker DA; Dines DE; Payne WS; Bernatz PE; Pairolero PC
Chest; 1978 Dec; 74(6):640-2. PubMed ID: 216532
[TBL] [Abstract][Full Text] [Related]
10. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
11. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
[TBL] [Abstract][Full Text] [Related]
12. [A study of lung cancer with presence of pleural effusion at the time of thoracotomy--cytologic evaluation of a relatively small amount of pleural effusion and prognosis after removal].
Usuda K; Saito Y; Ota S; Sato M; Takahashi S; Kanma K; Sagawa M; Nagamoto N; Fujimura S; Nakada T
Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):30-6. PubMed ID: 2329302
[TBL] [Abstract][Full Text] [Related]
13. Pleural effusion in breast cancer: a review of 105 cases.
Fentiman IS; Millis R; Sexton S; Hayward JL
Cancer; 1981 Apr; 47(8):2087-92. PubMed ID: 6261936
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
15. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Albain KS; Crowley JJ; Livingston RB
Chest; 1991 Jun; 99(6):1425-32. PubMed ID: 2036826
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
Shimokata K; Niwa Y; Yamamoto M; Sasou H; Morishita M
Chest; 1989 Mar; 95(3):602-3. PubMed ID: 2537710
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations.
Cantó A; Ferrer G; Romagosa V; Moya J; Bernat R
Chest; 1985 May; 87(5):649-52. PubMed ID: 2985340
[TBL] [Abstract][Full Text] [Related]
20. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
